Nemolizumab
Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus.
Product Specifications
CAS Number
1476039-58-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Interleukin
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
168825-APC 100 µL
MART-1 (Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA, Melan-A) (APC)
Sign In for Pricing
View Details 